Vaccine stocks have struggled since RFK Jr.'s appointment to health secretary, with Moderna and Pfizer seeing the deepest ...

To determine the type and severity of a cancer, pathologists typically analyze thin slices of a tumor biopsy under a microscope.

(RTTNews) - Flare Therapeutics has entered into a strategic discovery collaboration with Roche. The partnership will leverage Flare Therapeutics' proteomic and mass spectrometry platform, to discover ...

Flare Tx logo (PRNewsfoto/Flare Therapeutics) "Roche is an ideal partner for Flare Therapeutics because we share a commitment ...

People inherit two copies of each gene -; one from each parent -; an evolutionary fail-safe to ensure survival even when one of them doesn't function.

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...

The global AI in pathology market is projected to reach USD 169.8 million by 2029 from USD 82.8 million in 2024, at a high CAGR of ...

Yet, SERPRO has met with a group of Amazon Web Services (AWS) executives led by national security director Sean Roche, a former associate deputy director for digital innovation at the Central ...

Kevin Roche, Fairmount Park Conservancy’s chief of staff, said that 95% of city residents live less than 10 minutes from a park, and help is needed to “maintain and celebrate these shared public ...

After forming a gene therapy partnership with Dyno Therapeutics in 2020, Roche is back for more. In a new deal potentially worth more than $1 billion, Roche is paying Dyno $50 million upfront to ...

With an upfront payment of $50 million from Roche, the partnership will leverage Dyno Therapeutics’ in vivo gene therapy delivery technology, which synthesizes virus capsids with better functionality ...